Inhibikase Therapeutics, Inc. (IKT)

Market price: $1.60

1 valuation method

• P / B: $4.56 to $9.28 (midpoint $6.70)

Limited data — fewer than three valuation methods could be formed for this company; showing every method we can stand behind.